Capital Research Global Investors
Position in GILD — Gilead Sciences, Inc.
CIK 1422848
Los Angeles, CA
Position in GILD
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,450,149,016
-$1,330,615,258 QoQ
Shares Held
19,393,296
-28.5% QoQ
Ownership
1.56%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#14
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital Research Global Investors holds $40,525,577,269 across 9 Drug Manufacturers - General names. GILD ranks #3 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
20,873,140 | $25,035,872,397 | |
| 2 | ABBV |
AbbVie Inc.
|
30,101,551 | $7,574,754,293 | |
| 3 | GILD |
Gilead Sciences, Inc.
This page
|
19,393,296 | $2,450,149,016 | |
| 4 | AMGN |
Amgen Inc
|
6,272,625 | $2,271,442,965 | |
| 5 | JNJ |
Johnson & Johnson
|
8,164,545 | $2,073,549,493 | |
| 6 | AZN |
Astrazeneca PLC
|
4,197,587 | $795,946,446 | |
| 7 | MRK |
Merck & Co., Inc.
|
1,925,013 | $247,364,170 | |
| 8 | SNY |
Sanofi
|
1,677,399 | $71,557,841 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,450,149,016 | 19,393,296 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $3,780,764,274 | 27,127,533 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $3,106,189,894 | 25,307,071 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $3,331,559,106 | 30,014,046 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,447,799,670 | 31,097,679 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $6,119,091,958 | 54,610,370 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $5,352,493,080 | 57,946,228 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $5,181,284,416 | 61,799,671 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $4,145,945,457 | 60,427,714 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $4,486,296,309 | 61,246,366 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $4,832,823,777 | 59,657,126 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $4,340,053,277 | 57,913,708 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,462,327,489 | 57,899,669 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $4,835,334,537 | 58,278,107 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,687,663,429 | 54,602,952 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,323,577,744 | 53,875,470 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,459,875,323 | 55,975,980 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,326,309,481 | 55,951,379 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $7,780,668,390 | 107,156,981 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $8,001,185,343 | 114,548,108 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $8,034,003,277 | 116,671,555 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $7,924,047,624 | 122,606,338 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $7,088,633,965 | 121,672,399 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $7,400,386,077 | 117,113,247 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $9,644,958,501 | 125,356,882 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $7,175,638,168 | 95,982,319 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||